BMXMF
Price:
$125
Market Cap:
$12.30B
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subs...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-09-21
Stock Exchange
OTC
Ticker
BMXMF
According to bioMérieux S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.43B. This represents a change of 0.85% compared to the average of 12.32B of the last 4 quarters.
The mean historical Enterprise Value of bioMérieux S.A. over the last ten years is 10.01B. The current 12.43B Enterprise Value has changed 12.32% with respect to the historical average. Over the past ten years (40 quarters), BMXMF's Enterprise Value was at its highest in in the June 2020 quarter at 14.66B. The Enterprise Value was at its lowest in in the December 2005 quarter at 1.77B.
Average
10.01B
Median
10.60B
Minimum
4.56B
Maximum
14.43B
Discovering the peaks and valleys of bioMérieux S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 51.96%
Maximum Annual Enterprise Value = 14.43B
Minimum Annual Increase = -20.29%
Minimum Annual Enterprise Value = 4.56B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 12.23B | 1.55% |
| 2023 | 12.04B | 4.70% |
| 2022 | 11.50B | -20.29% |
| 2021 | 14.43B | 5.13% |
| 2020 | 13.73B | 41.44% |
| 2019 | 9.70B | 35.94% |
| 2018 | 7.14B | -19.81% |
| 2017 | 8.90B | 51.96% |
| 2016 | 5.86B | 28.46% |
| 2015 | 4.56B | 25.58% |
The current Enterprise Value of bioMérieux S.A. (BMXMF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
11.92B
5-year avg
12.79B
10-year avg
10.01B
bioMérieux S.A.’s Enterprise Value is greater than Mainz Biomed B.V. (1.82M), greater than Applied DNA Sciences, Inc. (2.86M), greater than Neuronetics, Inc. (89.91M), greater than Prenetics Global Limited (173.30M), greater than FONAR Corporation (76.00M), less than IQVIA Holdings Inc. (51.68B), less than Mettler-Toledo International Inc. (31.21B), greater than Twist Bioscience Corporation (1.85B), less than Waters Corporation (24.62B), less than ICON Public Limited Company (17.29B), less than Danaher Corporation (178.07B), less than Thermo Fisher Scientific Inc. (251.71B), greater than Charles River Laboratories International, Inc. (11.66B), greater than Invitae Corporation (1.50B), greater than CareDx, Inc (928.12M), less than Guardant Health, Inc. (14.19B), less than Illumina, Inc. (21.09B), less than Agilent Technologies, Inc. (43.61B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.82M | $4.79M | |
| 2.86M | $7.26M | |
| 89.91M | $99.30M | |
| 173.30M | $184.45M | |
| 76.00M | $90.34M | |
| 51.68B | $38.30B | |
| 31.21B | $29.07B | |
| 1.85B | $1.96B | |
| 24.62B | $23.60B | |
| 17.29B | $14.19B | |
| 178.07B | $162.74B | |
| 251.71B | $218.02B | |
| 11.66B | $9.06B | |
| 1.50B | $5.44M | |
| 928.12M | $998.35M | |
| 14.19B | $13.47B | |
| 21.09B | $19.56B | |
| 43.61B | $42.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bioMérieux S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like bioMérieux S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is bioMérieux S.A.'s Enterprise Value?
What is the highest Enterprise Value for bioMérieux S.A. (BMXMF)?
What is the 3-year average Enterprise Value for bioMérieux S.A. (BMXMF)?
What is the 5-year average Enterprise Value for bioMérieux S.A. (BMXMF)?
How does the current Enterprise Value for bioMérieux S.A. (BMXMF) compare to its historical average?